The global quinine market, driven by increasing health consciousness and rising awareness, is expected to witness substantial growth in the coming years. According to a recent report by Fairfield Market Research, the market was valued at approximately US$2.1 billion in 2022 and is projected to reach US$3.2 billion by 2030, with a CAGR of 6.5% between 2023 and 2030.
Market Drivers
Several key factors are contributing to the growth of the quinine market:
Increasing Demand for Tonic Water: Tonic water, containing quinine, is gaining popularity as a healthful beverage globally. With its exceptional therapeutic properties, including its use in malaria treatment and relieving leg cramps, quinine's market is expanding due to the rising global demand for tonic water.
Rising Cases of Malaria: The world has witnessed a surge in malaria cases, with over 14 million new cases reported in 2020, the highest levels since 2012. Quinine, an effective treatment for malaria, is expected to see increased demand due to the growing number of malaria patients.
Rising Alcoholic Beverage Consumption: Quinine is a key ingredient in some bitter alcoholic beverages like gin and tonic, which have gained popularity worldwide. This trend, along with the increasing popularity of alcoholic beverages like beer, wine, and spirits, is driving up the sales of quinine.
Market Challenges
Despite the promising growth, some challenges are impacting the quinine market:
Low Awareness Among Consumers: Quinine is often marketed as a mixer for alcoholic beverages, limiting its recognition as a versatile product with various uses.
Potential Health Issues: Some health complications, such as fever, headaches, and vision impairments, have been associated with quinine consumption, potentially affecting market growth.
Key Trends and Opportunities
The quinine market offers several opportunities for growth:
Product Innovations: Ongoing product innovation, including the use of quinine from natural sources and natural sweeteners, is expected to drive market expansion. Manufacturers are investing in research and development to create new flavors that cater to different consumer preferences.
Rising Consumer Spending Power: The increase in disposable income due to industrialization and economic progress is contributing to the growth of the quinine market. Urbanization and the influence of social media are also driving alcohol consumption and the demand for quinine.
Expanding Cocktail Culture: Tonic water is commonly used as a mixer in cocktails and mocktails, especially among gin and whisky drinkers. The growing cocktail culture is expected to open up new opportunities for the quinine sector.
Regional Outlook
North America: The North American region, including the U.S. and Canada, is expected to dominate the quinine market due to a high frequency of malaria and other mosquito-borne diseases. Additionally, the consumption of spirits like gin and tonic is on the rise.
Asia Pacific: The Asia Pacific region is projected to experience significant growth, driven by increased product approvals, rising awareness of malaria, and the consumption of spirits. India, China, and Indonesia are among the key markets driving demand.
Competitive Landscape
The quinine market is concentrated, with several major players driving innovation and expanding their distribution networks. Market consolidation is anticipated in the coming years. Some of the leading companies in the global quinine space include:
Aecochem Corp
Haihang Industry Co. Ltd.
Actavis
Shreeji Pharma International
Wockhardt
Vital Labs
Trademax Pharmaceuticals & Chemicals
Van Wankum Ingredients
Hangzhou Dayang Co. Ltd.
IS Chemical Technology Ltd.
Leocorno Enterprises
Bickford & Sons
Fever-Tree
Schweppes
Chempro Pharma Private Limited
Global Quinine Market is Segmented as Below:
By Type:
200 mg
300 mg
Other
By Application:
Problematic Leg Cramps
Malaria
Other
By Administration:
Oral Administration
Intramuscular Administration
Intravenous Administration
Others
By End User:
Hospitals
Clinics
Others
By Geographic Coverage:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Table of Contents
1. Executive Summary
1.1. Global Quinine Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2022
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Quinine Market Outlook, 2018 - 2030
3.1. Global Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
3.1.1. Key Highlights
3.1.1.1. 200 mg
3.1.1.2. 300 mg
3.1.1.3. Other
3.2. Global Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
3.2.1. Key Highlights
3.2.1.1. Problematic Leg Cramps
3.2.1.2. Malaria
3.2.1.3. Other
3.3. Global Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
3.3.1. Key Highlights
3.3.1.1. Oral Administration
3.3.1.2. Intramuscular Administration
3.3.1.3. Intravenous Administration
3.3.1.4. Others
3.4. Global Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
3.4.1. Key Highlights Snacks
3.4.1.1. Hospitals
3.4.1.2. Clinics
3.4.1.3. Others
3.5. Global Quinine Market Outlook, by Region, Value (US$ Mn), 2018 - 2030
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Quinine Market Outlook, 2018 - 2030
4.1. North America Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
4.1.1. Key Highlights
4.1.1.1. 200 mg
4.1.1.2. 300 mg
4.1.1.3. Other
4.2. North America Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
4.2.1. Key Highlights
4.2.1.1. Problematic Leg Cramps
4.2.1.2. Malaria
4.2.1.3. Other
4.3. North America Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
4.3.1. Key Highlights
4.3.1.1. Oral Administration
4.3.1.2. Intramuscular Administration
4.3.1.3. Intravenous Administration
4.3.1.4. Others
4.4. North America Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030